menu

AGC Biologics Acquires Molecular Medicine S.p.A,

Mergers & Acquisitions

AGC Biologics, a global biopharmaceutical contract development and manufacturing organization, acquired Molecular Medicine S.p.A., a clinical validation and R&D biotechnology company, for $238 million.

Morrow Sodali acted as the information agent for the bidder in this transaction.

Find more information here.

Subscribe

close

Sign up with your email